Hormone therapy in relation to survival from large bowel cancer (original) (raw)

• Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932. doi:10.1093/jnci/91.11.916
  Article PubMed CAS Google Scholar
• Csizmadi I, Collet JP, Benedetti A, Boivin JF, Hanley JA (2004) The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women. Br J Cancer 90:76–81. doi:10.1038/sj.bjc.6601438
  Article PubMed CAS Google Scholar
• Gambacciani M, Monteleone P, Sacco A, Genazzani AR (2003) Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Pract Res Clin Endocrinol Metab 17:139–147. doi:10.1016/S1521-690X(02)00086-6
  Article PubMed CAS Google Scholar
• Grodstein F, Newcomb PA, Stampfer MJ (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106:574–582. doi:10.1016/S0002-9343(99)00063-7
  Article PubMed CAS Google Scholar
• Chlebowski R, Wactawski-Wende J, Ritenbaugh C et al (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350:991–1004. doi:10.1056/NEJMoa032071
  Article PubMed CAS Google Scholar
• Prihartono N, Palmer JR, Louik C, Shapiro S, Rosenberg L (2000) A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer. Cancer Epidemiol Biomarkers Prev 9:443–447
  PubMed CAS Google Scholar
• Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333. doi:10.1001/jama.288.3.321
  Article PubMed CAS Google Scholar
• Newcomb PA, Storer BE (1995) Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87:1067–1071. doi:10.1093/jnci/87.14.1067
  Article PubMed CAS Google Scholar
• Newcomb PA, Zheng Y, Chia VM et al (2007) Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 67:7534–7539. doi:10.1158/0008-5472.CAN-06-4275
  Article PubMed CAS Google Scholar
• Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR (2007) Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 18:723–733. doi:10.1007/s10552-007-9015-7
  Article PubMed Google Scholar
• Hoffmeister M, Raum E, Winter J, Chang-Claude J, Brenner H (2007) Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. Br J Cancer 97:1486–1492. doi:10.1038/sj.bjc.6604066
  Article PubMed CAS Google Scholar
• Heiss G, Wallace R, Anderson GL et al (2008) Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 299:1036–1045. doi:10.1001/jama.299.9.1036
  Article PubMed CAS Google Scholar
• Mandelson MT, Miglioretti D, Newcomb PA, Harrison R, Potter JD (2003) Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 14:979–984. doi:10.1023/B:CACO.0000007970.04094.76
  Article PubMed Google Scholar
• Slattery ML, Anderson K, Samowitz W et al (1999) Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer. Cancer Causes Control 10:467–473. doi:10.1023/A:1008974215622
  Article PubMed CAS Google Scholar
• Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87:517–523. doi:10.1093/jnci/87.7.517
  Article PubMed CAS Google Scholar
• Ritenbaugh C, Stanford JL, Wu L et al (2008) Conjugated equine estrogens and colorectal cancer incidence and survival: The Women’s Health Initiative Randomized Clinical Trial. Cancer Epidemiol Biomarkers Prev 17:2609–2618. doi:10.1158/1055-9965.EPI-08-0385
  Article PubMed CAS Google Scholar
• Anderson GL, Limacher M, Assaf AR et al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 291:1701–1712. doi:10.1001/jama.291.14.1701
  Article PubMed CAS Google Scholar
• Hersh AL, Stefanick ML, Stafford RS (2004) National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291:47–53. doi:10.1001/jama.291.1.47
  Article PubMed CAS Google Scholar
• Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA (2005) Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 14:1212–1218. doi:10.1158/1055-9965.EPI-04-0845
  Article PubMed CAS Google Scholar
• Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A (2006) Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 17:63–70. doi:10.1007/s10552-005-0360-0
  Article PubMed Google Scholar
• Percy C, Van Holten V, Muir C (1990) International classification of diseases for oncology, 2nd edn. World Health Organization, Geneva
  Google Scholar
• Calle EE, Terrell DD (1993) Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol 137:235–241
  PubMed CAS Google Scholar
• Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Scientific Publications, Lyon
  Google Scholar
• Chan JA, Meyerhardt JA, Chan AT et al (2006) Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol 24:5680–5686. doi:10.1200/JCO.2006.08.0580
  Article PubMed CAS Google Scholar
• Persson I, Yuen J, Bergkvist L, Schairer C (1996) Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy—long-term follow-up of a Swedish cohort. Int J Cancer 67:327–332. doi:10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T
  Article PubMed CAS Google Scholar
• Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN (1995) Evidence of a healthy estrogen user survivor effect. Epidemiology 6:227–231
  PubMed CAS Google Scholar
• Zielinski SL (2005) Hormone replacement therapy for breast cancer survivors: an answered question? J Natl Cancer Inst 97:955
  Article PubMed Google Scholar
• Campbell-Thompson M, Lynch IJ, Bhardwaj B (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 61:632–640
  PubMed CAS Google Scholar